Getting you a comprehensive review of the product
Reading every ingredient in the formula…
Reading every ingredient in the formula…
Join The Clean Sheet™ community
Science-backed beauty tips, ingredient alerts, and early access. Straight to your WhatsApp.
Join for free →This is the most significant transparency concern in the Dot & Key range. The product is named and marketed as a 'Retinol' night cream, but the active ingredient in the ingredient list is Retinyl Palmitate, a retinol ester with substantially lower potency. Retinyl Palmitate requires two metabolic conversion steps to reach the active form (retinoic acid), versus one for actual Retinol. Clinical evidence for Retinyl Palmitate at cosmetic concentrations is materially weaker. Additionally, the INCI position of Retinyl Palmitate suggests low concentration. The product also contains three cosmetic dyes (CI 16185, CI 19140, CI 42090) and Parfum. The ceramide complex (Ceramide NP, AP, EOP) is genuinely present and beneficial, but the naming and ingredient mismatch is a clear disclosure concern.

₹549-₹899 • Analysed 11 June 2026
Anti-ageing actives are a growing segment in India, with consumers increasingly researching ingredients. The 'Retinol' naming creates a false equivalence with clinical retinol products. Indian consumers comparing this to The Ordinary Retinol or prescription Tretinoin will have misaligned expectations. The ceramide base is genuinely good, but the retinoid claim requires clear correction.
This is a web evidence review, not a Clean Sheet certification. We checked the ingredient list, publicly available test reports, marketing claims, and formula logic using only public information available at the time of review.
Active ingredient is Retinyl Palmitate, not Retinol. Two conversion steps to active form versus one for actual Retinol. Materially different bioavailability and potency at cosmetic concentrations.
Retinyl Palmitate at late INCI position suggests low concentration. Evidence for anti-ageing activity at likely concentrations is weak.
Ceramide NP/AP/EOP + Cholesterol is well-supported in published barrier science.
Public Evidence Score across 5 pillars. Open any row for the full rationale.
Parfum (synthetic fragrance) is present in this leave-on overnight cream. An overnight product sits on the skin for eight or more hours continuously, which significantly amplifies the sensitisation risk from fragrance compared to a rinse-off or daytime product. The specific allergens within 'Parfum' are not named. Three cosmetic azo dyes are also present - CI 16185 (Red 17), CI 19140 (Tartrazine), and CI 42090 (Brilliant Blue FCF) - making this the highest dye load in the Dot & Key range. None of them have any therapeutic benefit and all three carry documented allergen potential, with CI 19140 (Tartrazine) being a known cross-reactor in individuals with aspirin sensitivity. Retinyl Palmitate is a retinoid and warrants pregnancy precautions as a general category note.
The ceramide complex (NP, AP, EOP, and Cholesterol) is the formulation's genuine strength. Niacinamide adds anti-ageing and barrier benefit. Retinyl Palmitate appears late in the ingredient list, suggesting a low concentration, and it requires two metabolic conversion steps to reach the biologically active form. At a low concentration and with the added conversion barrier, meaningful anti-ageing retinoid activity in this product is unlikely. The three azo dyes and fragrance add no skin benefit while increasing sensitisation risk.
The product is named and marketed as a 'Retinol' night cream, but the retinoid ingredient in the ingredient list is Retinyl Palmitate - a different molecule with materially lower...
The product is named and marketed as a 'Retinol' night cream, but the retinoid ingredient in the ingredient list is Retinyl Palmitate - a different molecule with materially lower potency. Consumers comparing this to other retinol products or to clinical retinol recommendations will have a false sense of equivalence. The full ingredient list is published on dotandkey.com. Three azo dyes are present as pure colourants, but this is not communicated to consumers. The fragrance allergen breakdown is also not disclosed.
“Retinol (product name)” Active ingredient is Retinyl Palmitate, not Retinol. Two conversion steps to active form versus one for actual Retinol. Materially different bioavailability and potency at cosmetic concentrations.
“Anti-ageing / skin renewal (via retinoid)” Retinyl Palmitate at late INCI position suggests low concentration. Evidence for anti-ageing activity at likely concentrations is weak.
“Ceramide barrier benefit” Ceramide NP/AP/EOP + Cholesterol is well-supported in published barrier science.
No clinical study published for this product. The Retinol claim is not supported by INCI evidence. No consumer-accessible efficacy data. Grade D reflects the Retinyl Palmitate mislabelling and absence of test data for the primary claimed benefit.
Full INCI list published but the product name directly contradicts the INCI (Retinol vs Retinyl Palmitate). Three azo dyes present without communicating colourant purpose. Parfum without constituent disclosure. Significant clarity gap.
| Ingredient |
|---|
Aqua (Water) |
Glycerin |
Caprylic/Capric Triglyceride |
Ceramide NP |
Ceramide AP |
Ceramide EOP |
Cholesterol |
Niacinamide |
Retinyl Palmitate |
Parfum |
CI 16185 (Red 17) |
CI 19140 (Tartrazine) |
CI 42090 (Brilliant Blue FCF) |
Phenoxyethanol |
Ethylhexylglycerin |
INCI order as declared on packaging. Position reflects approximate concentration (high to low).
Parfum present in overnight leave-on product; constituent allergens not individually disclosed
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
Flags are based on publicly available INCI only. Not a substitute for full regulatory compliance review.
Active ingredient is Retinyl Palmitate, not Retinol. Two conversion steps to active form versus one for actual Retinol. Materially different bioavailability and potency at cosmetic concentrations.
Missing
Retinyl Palmitate at late INCI position suggests low concentration. Evidence for anti-ageing activity at likely concentrations is weak.
Mentioned only
Ceramide NP/AP/EOP + Cholesterol is well-supported in published barrier science.
Evidence visible
Public evidence the brand could provide to close verification gaps
The ceramide base is genuinely good. The Retinyl Palmitate mislabelled as Retinol is the most significant transparency concern in the entire Dot & Key range reviewed. Combined with Parfum and three azo dyes in an overnight format, this is the lowest-scoring product in the brand.
Are you the brand? If you have published test data or want to request a re-review, write to us at hello@thecleansheet.in.